Preview
Gonadotropin-releasing hormone (GnRH) agonists will have a significant impact on the practice of medicine in the 1990s. These agents will likely be given to increasing numbers of patients, and primary care physicians themselves may wish to prescribe the drugs when appropriate. This article describes the use of GnRH agonists in the treatment of endometriosis, advanced prostate cancer, and precocious puberty.
Additional information
Notes on contributors
Craig A. Winkel
Craig A. Winkel, MD Dr Winkel is professor and vice chairman, department of obstetrics and gynecology, and director, division of reproductive endocrinology, Jefferson Medical College, Philadelphia.